• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy Schumer says judge’s mifepristone abortion pill ruling ‘could throw our country into chaos’
Economy

Schumer says judge’s mifepristone abortion pill ruling ‘could throw our country into chaos’

by April 9, 2023
by April 9, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Senate Majority Leader Chuck Schumer, D-N.Y., railed against a Texas judge’s decision to halt Food and Drug Administration (FDA) approval of the abortion pill mifepristone, warning that it ‘could throw our country into chaos.’ 

‘This right-wing MAGA judge, in his zeal to impose his own views on the American people, has suspended this long time FDA-approved medication over the agency and the drug manufacturer’s opinion,’ Schumer told reporters on a press call Saturday.

In a highly controversial ruling, Trump-appointed U.S. District Judge Matthew J. Kacsmaryk issued an injunction against the FDA’s approval of mifepristone while a lawsuit challenging the drug’s safety and approval proceeds through federal court. The order is set to take effect seven days from the ruling. 

‘Before Plaintiffs filed this case, FDA ignored their petitions for over sixteen years, even though the law requires an agency response within ‘180 days of receipt of the petition,’’ Kacsmaryk wrote in his opinion. ‘Plaintiffs have credibly alleged past and future harm resulting from the removal of restrictions for chemical abortion drugs.’

The order was received with shock and indignation from the drug’s manufacturer, Danco Laboratories, as well as abortion rights groups and Democratic lawmakers. The Department of Justice took immediate action to appeal Kacsmaryk’s ruling to the U.S. Court of Appeals for the Fifth Circuit.

Democrats said the ruling was part of a Republican-led plot to ban abortion nationwide and strip away women’s rights. Schumer claimed that the court’s decision opened the door for other FDA-approved medications to be taken away by ‘extreme plaintiffs’ who come before any ‘extreme judge’ and ‘get their way.’ 

‘What could come next if some fringe radical group brings a lawsuit? Cancer drugs? Insulin? Mental health treatment?’ he asked. 

‘Make no mistake, the decision could throw our country into chaos. It’ll set a dangerous new precedent, and it will put lives in jeopardy,’ the Democratic leader said.

Sen. Patty Murray, D-Wash., who was also present on the call, added that the Texas ruling was part of an overarching Republican-led effort to capture the courts and ban abortion nationwide. 

‘This ruling is not about science, it is about ideology,’ she said. ‘It is not about protecting women. It’s about controlling their bodies. It is cruel, and it flies completely in the face of all reason and logic. And let’s not forget, this dangerous ruling threatens to absolutely upend FDA’s ability to approve all kinds of other safe medications, everything from insulin to chemotherapy drugs.’ 

Mifepristone, under the brand name Mifeprex, is part of a two-drug regimen that first blocks hormones needed to keep an unborn baby alive and then causes cramps and contractions to expel the dead fetus from the mother’s womb.

The drug was approved by the FDA in 2000. Since then, medication abortions, also called ‘chemical abortions,’ have grown in popularity and now make up nearly 60% of all abortions in the United States. More than five million women in the United States have used mifepristone to abort their pregnancies, according to the drug’s manufacturer. 

In the Texas case, four pro-life national medical associations and four doctors, represented by attorneys from the Alliance Defending Freedom (ADF), argue that the FDA ‘chose politics over science’ when it granted approval to mifepristone. Their lawsuit contests the FDA’s decision to define pregnancy as an ‘illness’ and its finding that mifepristone provides a ‘meaningful therapeutic benefit’ to women seeking an abortion, which expedited the drug’s approval. 

‘The FDA never studied the safety of the drugs under the labeled conditions of use, ignored the potential impacts of the hormone-blocking regimen on the developing bodies of adolescent girls, disregarded the substantial evidence that chemical abortion drugs cause more complications than surgical abortions, and eliminated necessary safeguards for pregnant girls and women who undergo this dangerous drug regimen,’ according to ADF. 

Nancy Northup, the CEO of the Center for Reproductive Rights, said the lawsuit and Kacsmaryk’s decision have ‘zero basis in law or fact.’ 

‘The judge relied on junk scientists who have been repeatedly discredited by many other courts as unreliable. His predetermined views are reflected throughout the opinion in his use of stigmatizing rhetoric of the anti-abortion rights movement,’ Northup asserted. 

‘This legal ruling is unprecedented. No medicine has ever been removed from the market over the FDA’s scientific objections. And while baseless, this decision could have a devastating impact if allowed to go into effect,’ she said. 

Pro-life groups applauded the decision as life-saving for unborn children and mothers. Texas Right to Life pointed to studies that show one in five women experience an adverse event after taking the abortion pill and that the rate of complications for medication abortions is four times higher than surgical abortions. Danco Laboratories, which sells Mifeprex, acknowledges that 3% of women who take the pill will ‘require surgical intervention for ongoing pregnancy, heavy bleeding, incomplete expulsion, or other reasons such as patient request.’

‘The FDA exists to protect Americans from dangerous drugs, yet it repeatedly ignored its legislative purpose in order to promote elective abortion at the expense of pregnant women and their preborn children,’ Texas Right to Life President Dr. John Seago said in a statement.

Physicians have said medication abortions are safe and effective. 

‘They are incredibly safe,’ Dr. Emily Godfrey, an associate professor of family medicine and obstetrics and gynecology at the University of Washington School of Medicine, told The Associated Press in 2022. ‘Less than 1% of people who have sought a medication abortion have had complications.’

Fox News’ Adam Sabes and the Associated Press contributed to this report.

Chris Pandolfo is a writer for Fox News Digital. Send tips to chris.pandolfo@fox.com and follow him on Twitter @ChrisCPandolfo.

This post appeared first on FOX NEWS
You Might Also Like
  • Former Watergate prosecutor calls Trump gag order ‘so unusual’: ‘This never happens’
  • Statement from RFK Jr contesting MAGA ties during committee hearing sparks fierce argument
  • Trump projected to win Republican presidential caucuses in American Samoa
  • Nebraska judiciary sees shortages in staff, mental health resources
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Catholic archdiocese accuses Walter Reed of stifling religious rights with ‘cease and desist’ order
next post
Ex-Gov. Andrew Cuomo faces new lawsuit alleging ‘unmitigated greed’ contributed to nursing home deaths

You may also like

Put policy aside: Kamala Harris will win or lose based...

August 20, 2024

Wisconsin’s liberal Supreme Court in crosshairs as GOP lawmakers grill...

August 23, 2023

Biden won’t make 2024 announcement until after State of the...

January 20, 2023

Prestige Wealth Inc. (PWM) Stock Price Analysis

September 20, 2024

Trump says taking a mugshot was ‘not a comfortable feeling,...

August 25, 2023

White House: Biden asserted executive privilege over Hur recordings at...

May 17, 2024

Hungary vetoes $54B European aid package for Ukraine, dealing Zelenskyy...

December 16, 2023

Pro-DeSantis super PAC rails against ‘woke’ ideology in new ad:...

June 26, 2023

House GOP launches investigation into federally funded news ratings group’s...

June 15, 2024

Gold and Silver: Gold moves to a new all-time high...

September 25, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Week Ahead: NIFTY Stays In A Defined Range; Moving Past This Level Crucial For Resumption Of Upmove

      May 31, 2025
    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025
    • Run Your Stock Portfolio Like a Pro Sports Team

      May 30, 2025
    • U.S. foreign tax bill sends jitters across Wall Street

      May 30, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,765 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,472 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,451 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,432 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,308 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,582)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Week Ahead: NIFTY Stays In A Defined Range; Moving Past...

      May 31, 2025
    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right...

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,582)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    1 in 3 Democrats believe Trump...

    July 21, 2024

    GREG GUTFELD: We’ve never seemed weaker,...

    April 16, 2024

    How Donald Trump sneaked up on...

    July 23, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here